The effect of Quercetin on doxorubicin Cytotoxicity in human breast cancer cells

Anti-Cancer Agents in Medicinal Chemistry

Volumn 13, Issue 2, 2013, Pages 352-355

  Li, Shi zheng ^a   Li, Kun ^a   Zhang, Jun hua ^a   Dong, Zhe ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Chemotherapy; Cytotoxicity; Doxorubicin; Quercetin

Indexed keywords

DOXORUBICIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MULTIDRUG RESISTANCE PROTEIN; QUERCETIN;

ARTICLE; BREAST CANCER; CELL INVASION; CELL PROLIFERATION; CHEMOSENSITIVITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG SYNERGISM; FEMALE; HUMANS; MCF-7 CELLS; QUERCETIN; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 84876732096     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/1871520611313020020     Document Type: Article

References (9)

1. Morse, R.; Rodgers, J.; Verrill, M.; Kendell, K. Neuro-psychological functioning following systemic treatment in women treated for breast cancer: a review. Eur. J. Cancer, 2003, 39(16), 2288-2297.
2. Linn, S.C.; Pinedo, H.M.; van Ark-Otte, J.; van der Valk, P.; Hoekman, K.; Honkoop, A.H.; Vermorken, J.B., Giaccone, G. Expression of drug resistance proteins in breast cancer in relation to chemotherapy. Int. J. Cancer, 1997, 71(5), 787-796.
3. Takahashi, N.; Li, W.; Banerjee, D.; Guan, Y.; Wada-Takahashi, Y.; Brennan, M.F.; Chou, T.C.; Scotto, K.W; Bertino, J.R. Sequence-dependent synergistic cytotoxicity of esteinascidin-743 and paclitaxel in human breast cancer cell lines in vitro and in vivo. Cancer Res., 2002, 62(23), 6909-6915.
4. Dai, C.L.; Liang, Y.J; Chen, L.M.; Zhang, X.; Deng, W.J.; Su, X.D.; Shi, Z.; Wu, C.P.; Ashby, C.R. Jr.; Akiyama, S.; Ambudkar, S.V; Chen, Z.S; Fu, L.W. Sensitization of ABCB1 overexpression cells to chemotherapeutic agents by FG020326 via binding to ABCB1, inhibiting its function. Biochem. Pharmacol., 2009, 78(4), 355-364.
5. Harris, A.L. Hypoxia--a key regulatory factor in tumour growth. Nat. Rev. Cancer, 2002, 2(1), 38-47.
6. Semenza, G.L.; Wang, G.L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell Biol., 1992, 12(12), 5447-5454.
7. Wang, G.L.; Jiang, B.H.; Rue, E.A.; Semenza, G.L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. U. S. A., 1995, 92(12), 5510-5514.
8. Birner, P.; Schindl, M.; Obermair, A.; Plank, C.; Breitenecker, G.; Oberhuber, G. Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res., 2000, 60(17), 4693-4696.
9. Nobili, S.; Landini, I.; Giglioni, B.; Mini, E. Pharmacological strategies for overcoming multidrug resistance. Curr. Drug Targets, 2006, 7(7), 861-879.